GENB 8-K 2026-08-25

Generate Biomedicines, Inc. (GENB) 8-K dated 2026-08-25 — accession 0001193125-26-365556. This URL is the filing, not the GENB hub.

Generate Biomedicines, Inc. (GENB) common stock.

Generate Biomedicines, Inc. filed a 8-K on 2026-08-25. Accession 0001193125-26-365556.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GENB revenue for 2026-06-30 was $13.5M. Net income was -$128.7M. Revenue was up 87.4% from 2026-03-31 to 2026-06-30. GENB currently screens at market cap $0.

Not investment advice. The GENB SEC hub lists recent forms. The stock page is the research view.